KEN HERRMANN

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 39% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
KEN HERRMANN's trades of Aktis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
185.09
Quantity 71,385 -12.0%
Value US$1,222,610
Transaction date
Sale
Price
164.83
Quantity 88,302 +47.3%
Value US$1,259,585
Transaction date
Proposed sale
Price
269.75
Quantity 33,674
Value US$1,469,602
Transaction date
Sale
Price
25.21
Quantity 3,065 -100.0%
Value US$77,259
Transaction date
Proposed sale
Price
25.21
Quantity 3,065
Value US$77,259
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-21 2026-07-20
S Sale
71,385 -12.0%
185.09
US$1,222,610 		71,385 -12.0% 185.09 US$1,222,610
2026-07-21 2026-07-20
S Sale
88,302 +47.3%
164.83
US$1,259,585 		88,302 +47.3% 164.83 US$1,259,585
2026-07-20 2026-07-20
PrS Proposed sale
33,674
269.75
US$1,469,602 		33,674 269.75 US$1,469,602
2026-07-20 2026-07-17
S Sale
3,065 -100.0%
25.21
US$77,259 		3,065 -100.0% 25.21 US$77,259
2026-07-17 2026-07-17
PrS Proposed sale
3,065
25.21
US$77,259 		3,065 25.21 US$77,259